Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIOX Bioceres Crop Solutions	$2.79 -2.8%	$3.69	$2.60 ▼ $11.39	$174.96M	0.44	271,285 shs	293,942 shs
EVE EVe Mobility Acquisition	$11.27	$11.27	$10.63 ▼ $11.30	$175.77M	N/A	9,163 shs	N/A
FTII FutureTech II Acquisition	$12.02 -2.3%	$11.99	$10.52 ▼ $14.00	$51.57M	-0.03	3,752 shs	500 shs
HLXB Helix Acquisition Corp. II	$9.99 -0.7%	$10.37	$8.50 ▼ $11.59	$188.81M	-0.14	125,529 shs	128,912 shs

7 Stocks to Ride The A.I. Megaboom

We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIOX Bioceres Crop Solutions	0.00%	-4.78%	-18.42%	-42.83%	-74.86%
EVE EVe Mobility Acquisition	0.00%	0.00%	0.00%	0.00%	+2.13%
FTII FutureTech II Acquisition	0.00%	-2.28%	-1.68%	+2.74%	+10.17%
HLXB Helix Acquisition Corp. II	0.00%	0.00%	-5.80%	-6.77%	-2.87%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BIOX Bioceres Crop Solutions	2.8612 of 5 stars	3.4	4.0	0.0	0.0	2.9	0.0	1.3
EVE EVe Mobility Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FTII FutureTech II Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
HLXB Helix Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIOX Bioceres Crop Solutions	2.80	Moderate Buy	$8.38	200.18% Upside
EVE EVe Mobility Acquisition	3.00	Buy	$5.00	-55.62% Downside
FTII FutureTech II Acquisition	0.00	N/A	N/A	N/A
HLXB Helix Acquisition Corp. II	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest FTII, HLXB, BIOX, and EVE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/21/2025	BIOX Bioceres Crop Solutions	Brookline Capital Management Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/15/2025	BIOX Bioceres Crop Solutions	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$7.00 ➝ $6.00

(Data available from 8/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIOX Bioceres Crop Solutions	$383.29M	0.46	$0.39 per share	7.16	$5.56 per share	0.50
EVE EVe Mobility Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
FTII FutureTech II Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
HLXB Helix Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIOX Bioceres Crop Solutions	$3.24M	-$0.14	N/A	7.34	1.19	-2.14%	-2.37%	-0.99%	9/8/2025 (Estimated)
EVE EVe Mobility Acquisition	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
FTII FutureTech II Acquisition	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
HLXB Helix Acquisition Corp. II	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest FTII, HLXB, BIOX, and EVE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
9/8/2025	Q4 2025	BIOX Bioceres Crop Solutions	$0.10	N/A	N/A	N/A	$110.23 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIOX Bioceres Crop Solutions	N/A	N/A	N/A	N/A	N/A
EVE EVe Mobility Acquisition	N/A	N/A	N/A	N/A	N/A
FTII FutureTech II Acquisition	N/A	N/A	N/A	N/A	N/A
HLXB Helix Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIOX Bioceres Crop Solutions	0.22	1.02	0.74
EVE EVe Mobility Acquisition	N/A	N/A	N/A
FTII FutureTech II Acquisition	N/A	N/A	N/A
HLXB Helix Acquisition Corp. II	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIOX Bioceres Crop Solutions	17.68%
EVE EVe Mobility Acquisition	N/A
FTII FutureTech II Acquisition	65.83%
HLXB Helix Acquisition Corp. II	54.89%

Insider Ownership

Company	Insider Ownership
BIOX Bioceres Crop Solutions	2.31%
EVE EVe Mobility Acquisition	57.70%
FTII FutureTech II Acquisition	9.30%
HLXB Helix Acquisition Corp. II	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIOX Bioceres Crop Solutions	500	62.71 million	61.26 million	Optionable
EVE EVe Mobility Acquisition	4	15.60 million	6.60 million	Not Optionable
FTII FutureTech II Acquisition	2	4.29 million	2.26 million	Not Optionable
HLXB Helix Acquisition Corp. II	N/A	18.91 million	N/A	N/A

FTII, HLXB, BIOX, and EVE Headlines

Recent News About These Companies

BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition

August 11, 2025 | tmcnet.com

Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics

August 6, 2025 | globenewswire.com

Helix Acquisition Corp. II and BridgeBio Oncology Therapeutics Announce Effectiveness of Registration Statement for Proposed Business Combination

July 11, 2025 | globenewswire.com

Boston SPAC company picks partner to take public

March 1, 2025 | bizjournals.com

BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3KÎ±-Targeting Medicines

February 28, 2025 | businesswire.com

Helix Acquisition Corp. II appoints new independent director

February 10, 2025 | msn.com

SPAC Artius II Acquisition Files for $200M IPO

November 6, 2024 | marketwatch.com

HLXB Helix Acquisition Corp. II

October 8, 2024 | seekingalpha.com

Helix Acquisition Corp. II Announces Closing of $184 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares

February 14, 2024 | businesswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTII, HLXB, BIOX, and EVE Company Descriptions

Bioceres Crop Solutions NASDAQ:BIOX

$2.79 -0.08 (-2.79%)

Closing price 08/29/2025 04:00 PM Eastern

Extended Trading

$2.82 +0.03 (+1.22%)

As of 08/29/2025 07:04 PM Eastern

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

EVe Mobility Acquisition NYSE:EVE

$11.27 0.00 (0.00%)

As of 08/29/2025

EVe Mobility Acquisition Corp does not have significant operations. The company focuses on effectuating a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on the automotive and mobility industry. The company was incorporated in 2021 and is based in Wilmington, Delaware.

FutureTech II Acquisition NASDAQ:FTII

$12.02 -0.28 (-2.28%)

As of 08/29/2025 11:07 AM Eastern

FutureTech II Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire and manage a business in the technology industry. The company was incorporated in 2021 and is based in New Rochelle, New York.

Helix Acquisition Corp. II NASDAQ:HLXB

$9.98 -0.08 (-0.75%)

Closing price 08/11/2025

Extended Trading

$9.98 0.00 (0.00%)

As of 08/11/2025 07:56 PM Eastern

Helix Acquisition Corp. II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Boston, Massachusetts. Helix Acquisition Corp. II is a subsidiary of Helix Holdings II LLC.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time